IGF2BP3 binds to the SENP1 3′‐UTR in an m6A‐dependent manner, enhancing SENP1 expression and activating the AKT signaling pathway, which contributes to AML malignancy.267. Here, SENP1 is linked to acute myeloid leukemia.